Five years of U.S. real-world evidence reinforce the durable effectiveness and long-term persistence of ViiV Healthcare’s Cabenuva
GSK PLC GSK
News
Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
GSK Says FDA Approved Jemperli For Certain Types of Rectal Cancer
GSK Says Lung-Cancer Drug Shows Benefits in Global Trial
Flu season is already here. Here's what to know about this year's flu shots.
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
European Pharma Leaders Push for National Reforms to Boost Investment
ViiV Healthcare Partners with Prevention Access Campaign (PAC) to Celebrate 10 Years of U=U and Look to The Future
Is the shingles vaccine the secret to living longer and delaying dementia? Here's what the science says.
Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.
GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment
Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial
GSK's Rectal Cancer Drug Jemperli Accepted for Priority Review by FDA
ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline — Update
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline
GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers
GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment
United States